These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29895360)

  • 21. Hepatic features of Wilson disease.
    Boga S; Ala A; Schilsky ML
    Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.
    Gromadzka G; Karpińska A; Przybyłkowski A; Litwin T; Wierzchowska-Ciok A; Dzieżyc K; Chabik G; Członkowska A
    Biometals; 2014 Feb; 27(1):207-15. PubMed ID: 24368744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mtDNA depletion-like syndrome in Wilson disease.
    Medici V; Sarode GV; Napoli E; Song GY; Shibata NM; Guimarães AO; Mordaunt CE; Kieffer DA; Mazi TA; Czlonkowska A; Litwin T; LaSalle JM; Giulivi C
    Liver Int; 2020 Nov; 40(11):2776-2787. PubMed ID: 32996699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
    Zhang JW; Liu JX; Hou HM; Chen DB; Feng L; Wu C; Wei LT; Li XH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):82-5. PubMed ID: 25634697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.
    Sarode GV; Kim K; Kieffer DA; Shibata NM; Litwin T; Czlonkowska A; Medici V
    Metabolomics; 2019 Mar; 15(3):43. PubMed ID: 30868361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia.
    Attri S; Sharma N; Jahagirdar S; Thapa BR; Prasad R
    Pediatr Res; 2006 Apr; 59(4 Pt 1):593-7. PubMed ID: 16549536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate.
    Ogra Y; Miyayama T; Anan Y
    J Inorg Biochem; 2010 Aug; 104(8):858-62. PubMed ID: 20427090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing and gauging of D-Penicillamine xenobiotics in hepatic Wilson disease patients.
    Gupta A; Sen Sarma M; Kumar A; Meena K; Baishya B; Mathias A; Mishra AK; Rao NK; Singh N; Singh P
    Biophys Chem; 2024 Oct; 313():107306. PubMed ID: 39121649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
    Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilson disease in pregnancy: A case series.
    Xiong X; Wei H; Zhu Y; Zhou X; Zhao Z; Chen Q
    Medicine (Baltimore); 2023 Feb; 102(7):e32968. PubMed ID: 36800617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models.
    Zischka H; Lichtmannegger J
    Ann N Y Acad Sci; 2014 May; 1315():6-15. PubMed ID: 24517326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of oxidative events and copper accumulatıon in oral tissues of patients wıth Wilson's disease: three case report.
    Ozturk M; Karacelebi E; Gungor K; Coskun S; Boysan E
    Int J Clin Exp Pathol; 2015; 8(4):3943-5. PubMed ID: 26097579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plasma Mass Spectrometry.
    Kim P; Zhang CC; Thoröe-Boveleth S; Weiskirchen S; Gaisa NT; Buhl EM; Stremmel W; Merle U; Weiskirchen R
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32948070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease.
    Kirk FT; Munk DE; Swenson ES; Quicquaro AM; Vendelbo MH; Larsen A; Schilsky ML; Ott P; Sandahl TD
    J Hepatol; 2024 Apr; 80(4):586-595. PubMed ID: 38081365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilson disease-treatment perspectives.
    Litwin T; Dzieżyc K; Członkowska A
    Ann Transl Med; 2019 Apr; 7(Suppl 2):S68. PubMed ID: 31179305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of the hepatic tissue of Long-Evans Cinnamon (LEC) rats according to the natural course of Wilson disease.
    Lee BH; Kim JM; Heo SH; Mun JH; Kim J; Kim JH; Jin HY; Kim GH; Choi JH; Yoo HW
    Proteomics; 2011 Sep; 11(18):3698-705. PubMed ID: 21751376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of using exchangeable copper and the ratio of exchangeable copper in a real-world cohort of patients with Wilson disease.
    Mariño Z; Molera-Busoms C; Badenas C; Quintero-Bernabeu J; Torra M; Forns X; Artuch R
    J Inherit Metab Dis; 2023 Sep; 46(5):982-991. PubMed ID: 37254446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.
    Weiskirchen S; Kim P; Weiskirchen R
    Ann Transl Med; 2019 Apr; 7(Suppl 2):S72. PubMed ID: 31179309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.